The European ADHD Guidelines Group replies

Autor: Samuele Cortese, Daniel Brandeis, Martin Holtmann, Edmund J.S. Sonuga-Barke, Philip Asherson, Tobias Banaschewki, Jan Buitelaar, David Coghill, David Daley, Marina Danckaerts, Ralf W. Dittmann, Manfred Doepfner, Maite Ferrin, Chris Hollis, Eric Konofal, Michel Lecendreux, Aribert Rothenberger, Paramala Santosh, Emily Simonoff, César Soutullo, Hans-Christoph Steinhausen, Argyris Stringaris, Eric Taylor, Saskia Van der Oord, Ian Wong, Alessandro Zuddas

Publikováno v: Journal of the American Academy of Child and Adolescent Psychiatry, 55, 1092-1093
Journal of the American Academy of Child and Adolescent Psychiatry, 55, 12, pp. 1092-1093

Dr. Micoulaud-Franchi et al. raise concerns relating to our 2016 meta-analysis1 of neurofeedback as a treatment for attention-deficit/hyperactivity disorder (ADHD). It is encouraging that Dr. Micoulaud-Franchi et al. agree with us that there is “an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3caba960701fe7763120d613a40b03
https://eprints.soton.ac.uk/401521/